{"id":"https://openalex.org/W4256166205","doi":"https://doi.org/10.1093/neuonc/noaa049","title":"Highlights from the literature","display_name":"Highlights from the literature","publication_year":2020,"publication_date":"2020-04-01","ids":{"openalex":"https://openalex.org/W4256166205","doi":"https://doi.org/10.1093/neuonc/noaa049"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noaa049","doi":"https://doi.org/10.1093/neuonc/noaa049","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noaa049","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/22/4/446/33047075/noaa049.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/22/4/446/33047075/noaa049.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080482957","display_name":"Wolfgang Wick","orcid":"https://orcid.org/0000-0002-6171-634X","observed_orcids":["https://orcid.org/0000-0002-6171-634X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wolfgang Wick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044442671","display_name":"Roger Abounader","orcid":"https://orcid.org/0000-0003-4075-9460","observed_orcids":["https://orcid.org/0000-0003-4075-9460"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roger Abounader","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084589096","display_name":"Alain Charest","orcid":"https://orcid.org/0000-0002-1548-6950","observed_orcids":["https://orcid.org/0000-0002-1548-6950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alain Charest","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019103647","display_name":"Holly Lindsay","orcid":"https://orcid.org/0000-0001-5654-841X","observed_orcids":["https://orcid.org/0000-0001-5654-841X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Holly Lindsay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083288793","display_name":"Murali Chintagumpala","orcid":"https://orcid.org/0000-0003-2686-6737","observed_orcids":["https://orcid.org/0000-0003-2686-6737"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Murali Chintagumpala","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060494950","display_name":"Stephen C. Mack","orcid":"https://orcid.org/0000-0001-9620-4742","observed_orcids":["https://orcid.org/0000-0001-9620-4742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen C Mack","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5063290790","display_name":"Kenneth Aldape","orcid":"https://orcid.org/0000-0001-5119-7550","observed_orcids":["https://orcid.org/0000-0001-5119-7550"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth Aldape","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.30563798,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"4","first_page":"446","last_page":"449"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9010000228881836},{"id":"https://openalex.org/keywords/patient-derived-organoids","display_name":"patient-derived organoids","score":0.7960000038146973},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.7179999947547913},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.953000009059906},{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.6359999775886536},{"id":"https://openalex.org/keywords/tumor-evolution","display_name":"tumor evolution","score":0.37299999594688416},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.44999998807907104},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.6800000071525574},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.5170000195503235},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8690000176429749},{"id":"https://openalex.org/keywords/metastatic-sites","display_name":"metastatic sites","score":0.3700000047683716},{"id":"https://openalex.org/keywords/clonal-selection","display_name":"clonal selection","score":0.5009999871253967}],"concepts":[{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.31370940804481506}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noaa049","doi":"https://doi.org/10.1093/neuonc/noaa049","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noaa049","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/22/4/446/33047075/noaa049.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7158651","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7158651","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noaa049","doi":"https://doi.org/10.1093/neuonc/noaa049","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noaa049","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/22/4/446/33047075/noaa049.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4256166205.pdf","grobid_xml":"https://content.openalex.org/works/W4256166205.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2997979341","https://openalex.org/W2588635922","https://openalex.org/W7165483822","https://openalex.org/W2594735980","https://openalex.org/W2976292707","https://openalex.org/W7046518329","https://openalex.org/W3015179648","https://openalex.org/W4409868323","https://openalex.org/W3107504261","https://openalex.org/W4294680049"],"abstract_inverted_index":{"Relevant":[0],"patient-derived":[1,181],"models":[2,14,57,103,113,1097],"may":[3],"help":[4],"to":[5,16,28,86,127,133,146,208,364,436,445,468,570,600,665,686,741,775,920,941,946,956,989,1003,1094,1161,1297,1305,1322,1361,1442,1516,1581,1610,1635,1712,1738,1804,1950,1984,2002,2040,2062],"interrogate":[6],"clinical":[7],"and":[8,13,15,83,124,129,137,151,174,177,197,236,239,264,296,311,314,346,374,377,391,433,464,508,539,583,587,624,655,671,678,706,734,791,795,848,881,913,925,938,977,998,1039,1055,1112,1116,1138,1158,1211,1218,1282,1301,1303,1309,1339,1351,1376,1404,1417,1426,1474,1478,1578,1601,1613,1647,1661,1694,1704,1719,1724,1774,1798,1869,1912,1928,2017,2026,2048,2101],"molecular":[9,488,1418,1824,2076],"data":[10,906,1044,1051],"from":[11,70,218,328,1052,1122,1444,1493,1519,1654,1792],"patients":[12,400,442,1797],"work":[17,454],"on":[18,622,703,711,774,781,805,823,841,860,863,1524,1894,2074],"clinically":[19],"relevant":[20,1595,1603],"questions":[21],"of":[22,25,36,99,156,163,179,190,231,247,281,309,317,323,331,357,389,398,406,414,438,492,518,523,544,575,614,617,632,659,695,701,720,751,758,838,898,933,951,966,1022,1025,1035,1049,1064,1070,1087,1098,1135,1201,1228,1233,1237,1270,1280,1287,1343,1363,1369,1381,1389,1400,1420,1472,1487,1540,1554,1599,1620,1659,1668,1681,1697,1742,1786,1802,1826,1844,1863,1881,1889,1897,1914,1921,1926,1958,1960,1977,1988,2008,2044,2050,2057,2094],"the":[23,34,87,90,122,134,138,202,215,229,245,254,381,415,450,483,516,615,641,644,681,692,699,718,749,768,778,785,850,871,876,905,952,964,979,1023,1026,1030,1053,1095,1114,1131,1155,1190,1264,1267,1271,1278,1288,1370,1379,1382,1390,1401,1415,1564,1627,1676,1698,1714,1736,1740,1756,1771,1784,1800,1823,1841,1849,1864,1873,1885,1924,1945,1973,1991,2018,2041,2045,2095],"contribution":[24],"glioblastoma":[26,182,210,540,934],"heterogeneity":[27,932,958],"treatment":[29,46,466,503,1803,2007],"resistance":[30,599,1304],"as":[31,33,589,591,873,1169,1550,1574,1764,1766,1831,1833],"well":[32,590,1765,1832],"role":[35,1250],"evolutionary":[37],"programs":[38,1605,2066],"during":[39,1450],"spontaneous":[40],"tumor":[41,79,220,393,418,995,1015,1115,1510,1521,1562,1569,1637,1699,1715],"progression":[42],"or":[43,73,77,250,283,473,1126,1291,1857,1884,1887],"development":[44],"under":[45],"pressure.":[47],"Patient-derived":[48],"xenografts":[49],"(PDX)":[50],"with":[51,104,334,504,525,763,875,887,901,963,1081,1331,1355,1378,1532,1558,1964,1972,2011],"variable":[52,82],"sources":[53],"are":[54,109,118,125,143,443,783,825,855,867,1091,1206,1222,1335,1365,1440,1579,1652,1664],"heavily":[55],"used":[56,256],"requiring":[58],"host":[59],"mice.":[60],"The":[61,320,453,542,713,755,809,828,929,1182,1640,1745],"tissue":[62,69],"source":[63],"(full":[64],"pretreatment":[65],"tumor,":[66,1080],"post-treatment":[67],"tissue,":[68],"metastatic":[71],"sites":[72],"minimal":[74],"residual":[75],"disease":[76],"circulating":[78],"cells)":[80],"is":[81,93,214,533,722,818,910,936,939,959,1315,1733,1748],"chosen":[84],"according":[85],"hypothesis":[88],"examined;":[89],"mouse":[91,1597],"model":[92,184,213,1216],"usually":[94],"immune":[95,1005],"compromised,":[96],"but":[97,117,272,286,559],"examples":[98],"challenging":[100],"humanized":[101],"PDX":[102],"a":[105,160,169,180,225,275,300,306,329,355,361,460,534,636,894,943,972,1013,1019,1046,1062,1078,1106,1123,1150,1170,1198,1213,1249,1253,1316,1336,1458,1468,1728,1751,1811,1918,2013],"lengthy":[106],"humanization":[107],"process":[108,226],"available.":[110],"In":[111,159,635,843,971,1128,1556,1810,1840],"vitro":[112,1210],"might":[114,481],"be":[115,482,942,1162,1517,1739],"easier":[116],"less":[119,868,1965],"complex,":[120],"lacking":[121],"microenvironment,":[123],"subject":[126],"genetic":[128,1393],"post-translational":[130],"changes":[131],"due":[132],"cultivation":[135],"processes":[136],"media":[139],"growth":[140,251,325,602,1300],"factors":[141],"that":[142,185,227,598,625,648,717,767,777,801,812,819,853,891,908,993,1011,1061,1103,1105,1117,1174,1186,1246,1567,1650,1662,1732],"not":[144,269,456,1159],"favorable":[145],"maintaining":[147],"various":[148,194,1004],"cellular":[149,195,277,931,1416,1583,1679,2097],"subtypes":[150],"key":[152,1235],"driver":[153,1741],"gene":[154,192,1385,1762,2064],"expression":[155,316,798,833,918,1543,1696,1959,2065],"parental":[157,203,392],"tumors.":[158,576,1683],"recent":[161,638,973,1412,1459],"issue":[162],"Cell,":[164],"Jacob":[165],"et":[166,1465,1816],"al":[167,1466],"present":[168,1163],"workable,":[170],"fast":[171],"(1\u20132":[172],"weeks),":[173],"effective":[175,432],"workflow":[176],"paradigm":[178],"organoid":[183,211,1215],"allows":[186,228,650],"for":[187,336,343,348,367,520,556,651,815,831,1285,1596,1607,2083],"valid":[188],"recapitulation":[189],"mutations,":[191],"expression,":[193,1916],"states,":[196],"also":[198,240,273,287,353,371,1275,1982],"histological":[199],"features":[200,448,1269],"mimicking":[201],"glioblastoma.1":[204],"An":[205],"important":[206,1411,2037],"difference":[207],"established":[209],"(GBO)":[212],"generation":[216],"directly":[217],"fresh":[219],"specimens":[221],"without":[222,1846],"single-cell":[223,382,967,1050,1469],"dissociation,":[224],"maintenance":[230,1302,1693],"potentially":[232],"critical":[233,362,1153],"cell-cell":[234],"contacts":[235],"communication":[237],"2":[238],"avoids":[241],"clonal":[242],"selection":[243],"by":[244,581,596,611,975,985,1041,1367,1480,1629,1644,1666,1735,1750,1755,1767,1814,1997,2078],"avoidance":[246],"matrix":[248],"compounds":[249],"factors.":[252],"Instead,":[253],"protocol":[255],"H+GPSA":[257],"medium":[258],"containing":[259],"Hibernate":[260],"A,":[261],"L-glutamine,":[262],"penicillin/streptomycin,":[263],"amphotericin":[265],"B.1":[266],"GBO":[267,304,324,366,390,465,519],"demonstrated":[268,647,1185,1956],"only":[270,573,803],"qualitatively":[271],"quantitatively":[274],"similar":[276,447,988,1906],"composition,":[278,1029],"i.e.":[279],"level":[280,356,384],"OLIG2-":[282],"SOX2-positive":[284],"cells,":[285,291,394,1483],"bona":[288],"fide":[289],"precursor":[290],"diversely":[292],"proliferating":[293,997],"cell":[294,410,502,506,1006,1028,1037,1065,1101,1109,1120,1125,1140,1152,1172,1313,1445,1489,1496,1528,1593,1638,1692,1920],"progenies":[295],"non-neoplastic":[297,396],"cells.":[298,754,1970],"As":[299,360],"limitation,":[301],"over":[302,1799],"time":[303],"showed":[305,716,811,890,907],"decreased":[307,1695],"abundance":[308],"vasculature":[310],"macrophage/microglia":[312],"populations":[313,1290,1497],"lower":[315],"immune-related":[318],"genes.":[319],"success":[321],"rate":[322],"was":[326,386,430,497,562,568,609,627,760,834],"91.4%":[327],"total":[330],"53":[332],"patients,":[333],"66.7%":[335],"isocitrate":[337],"dehydrogenase":[338],"(IDH)1":[339],"mutant":[340],"tumors,":[341,351,1437],"75%":[342],"recurrent":[344,1794,1929,1946],"tumors":[345,434,1083,1330,1346,1658,1980],"96.4%":[347],"primary":[349,1828,1927,1968],"IDH1-wildtype":[350],"differential":[352],"at":[354,404],"subregional":[358],"clones.":[359],"prerequisite":[363],"use":[365],"targeted":[368,474],"analyses,":[369],"GBOs":[370],"maintain":[372],"inter-":[373],"intra-tumoral":[375,930],"transcriptomic":[376,383],"genomic":[378,1618,1909,1975,2042],"heterogeneity.1":[379],"At":[380],"there":[385],"patient-specific":[387,1014],"clustering":[388],"whereas":[395],"cells":[397,1000,1073,1221,1549,1553,1570,2010],"several":[399],"clustered":[401,1531,1870,1892],"together.":[402],"Looking":[403],"levels":[405,1987],"recently":[407],"described":[408,444],"transcription":[409,668],"types,3":[411],"again,":[412],"similarities":[413],"paired":[416],"GBO-primary":[417],"distribution":[419],"remained":[420],"stable.":[421],"Engraftment":[422],"into":[423,1592],"female":[424],"4\u20138-week-old":[425],"athymic":[426],"nude":[427],"(NU/J)":[428],"mice":[429],"very":[431,1352],"prone":[435],"formation":[437,2025],"distant":[439],"satellites":[440],"in":[441,449,458,471,477,529,537,550,572,585,607,620,629,640,662,669,789,870,1001,1154,1164,1180,1209,1212,1225,1231,1251,1259,1295,1349,1395,1457,1461,1615,1623,1689,1808,1819,1821,1855,1937,1944,1990,2055,2088],"display":[446],"intracranial":[451],"model.":[452],"did":[455],"suffice":[457],"establishing":[459],"correlation":[461],"between":[462,1770],"patient":[463,1511],"responses":[467,524],"radiation,":[469],"temozolomide":[470],"vitro,":[472],"experimental":[475],"treatments":[476],"vivo.":[478,1226],"A":[479],"reason":[480,814,830],"low":[484],"sample":[485],"number,":[486],"although":[487],"signatures":[489,1492],"were":[490,739,802,1498,1514,1710,1838,1931,1935,1942,1981],"predictive":[491],"pathway-directed":[493],"therapies.":[494],"Also":[495],"successful":[496],"an":[498,1008,1033,1356,2058],"anti-EGFRvIII+":[499],"GBO-specific":[500],"CAR-T":[501,505],"expansion":[507],"specific":[509],"toxicity":[510],"sparing":[511],"EGFR+":[512],"GBO,":[513],"all-in-all":[514],"showing":[515,597],"utility":[517],"rapid":[521],"testing":[522],"this":[526,594,816,957,1118,1396,1455],"endogenous":[527],"target":[528],"culture.":[530],"Oncogene":[531],"amplification":[532,1368,1862],"common":[535,1919],"event":[536],"cancer":[538,753,793,1099],"(GBM).":[541],"presence":[543,1886],"large":[545],"circular":[546,693,746,756,882,912],"extrachromosomal":[547],"DNA":[548,807,820,922,1899,2004,2029],"(ecDNA)":[549],"human":[551,633,1057,1473,1503],"cancers":[552],"has":[553,893,1407],"been":[554,1408],"known":[555,1199],"many":[557],"years,":[558],"its":[560],"importance":[561],"previously":[563],"underestimated.":[564],"Until":[565],"recently,":[566],"ecDNA":[567,626,649,702,721,745,759,782,824,861,892,909],"thought":[569,940,1441],"occur":[571],"1.4%":[574],"Two":[577],"seminal":[578],"papers":[579],"published":[580,1622,1818],"Mischel":[582],"colleagues":[584],"2014":[586],"2017":[588],"others":[592],"changed":[593],"perspective":[595],"epidermal":[601],"factor":[603],"receptor":[604,1194],"(EGFR)":[605],"inhibitors":[606],"GBM":[608,670,790,1036,1220,1261,1299],"conferred":[610],"reversible":[612],"loss":[613],"gain":[616,1018],"function":[618],"mutation":[619],"EGFRvIII":[621],"ecDNA1":[623],"found":[628,992,1060,1711,1983],"nearly":[630],"half":[631],"cancers.2":[634],"third":[637],"publication":[639],"journal":[642],"Nature,":[643],"same":[645],"group":[646,1342],"high":[652,656,667,1986],"copy":[653,821,923],"number":[654,897],"chromatin":[657,709,836,927],"accessibility":[658,710,837],"oncogenes,":[660],"which":[661,1484,1530,1630],"turn":[663],"leads":[664],"their":[666,1043,1129,1293,1525,1761],"other":[672,792,990,1234,1520,1559,1655,1793,1858],"cancers.3":[673],"Using":[674,725],"multiple":[675,1085,1311],"advanced":[676],"sequencing":[677,969],"microscopy":[679],"techniques,":[680],"research":[682,1424],"team":[683],"set":[684],"out":[685,1277],"address":[687],"three":[688,2033],"questions:":[689],"1)":[690],"verify":[691],"nature":[694,757],"ecDNA;":[696],"2)":[697],"determine":[698],"effects":[700],"oncogene":[704,917],"expression;":[705],"3)":[707],"assess":[708],"ecDNA.":[712,842],"authors":[714,769,810,851,980,1031,1132,1183,1265,1565,1641,1737,1850],"first":[715,1317,1642],"structure":[719],"indeed":[723,911],"circular.":[724],"super-resolution,":[726],"three-dimensional":[727],"structured":[728],"illumination":[729],"microscopy,":[730,733,737],"scanning":[731],"electron":[732,736],"transmission":[735],"they":[738,889,1274,1663],"able":[740,1515],"visualize":[742],"individual,":[743],"fixed":[744],"structures":[747,1995],"within":[748,1077],"nuclei":[750],"different":[752],"further":[761],"verified":[762],"computational":[764],"reconstruction":[765],"tools":[766],"developed.":[770],"They":[771,1059],"then":[772,1184,1499],"went":[773],"show":[776],"oncogenes":[779,800],"located":[780,804,840,859],"among":[784],"highest":[786],"expressed":[787,1176,1384,1448],"genes":[788,839,1069,1179,1687,1963],"genomes":[794],"exhibited":[796],"higher":[797],"than":[799,862,1967],"chromosomal":[806],"(chrDNA).":[808],"one":[813],"increase":[817,916],"numbers":[822,924],"greatly":[826],"increased.":[827],"second":[829],"increased":[832,921,1943,2003,2023,2028],"enhanced":[835,926],"fact,":[844],"using":[845,879],"ChIP-seq,":[846],"ATAC-seq,":[847],"MNase-seq,":[849],"determined":[852],"chromatins":[854],"more":[856,1207,1223],"accessible":[857],"when":[858],"chrDNA":[864],"because":[865],"nucleosomes":[866],"condensed":[869],"former":[872],"compared":[874],"latter.":[877],"Finally,":[878],"PLAC-seq":[880],"chromosome":[883,1371],"conformation":[884],"capture":[885],"combined":[886],"4C-seq,":[888],"significantly":[895],"greater":[896],"ultra-long-range":[899],"interactions":[900,1769],"active":[902],"chromatin.":[903],"Altogether,":[904],"can":[914,1110],"markedly":[915],"owing":[919],"accessibility.":[928],"(GBM)":[935],"notorious":[937],"significant":[944],"contributor":[945],"therapeutic":[947,1429,2081,2103],"inefficiency.":[948],"Our":[949],"understanding":[950,1021,1399,2093],"mechanisms":[953,1628],"giving":[954],"rise":[955],"now":[960],"becoming":[961],"clearer":[962],"advent":[965],"RNA":[968,1999],"technologies.":[970],"report":[974],"Bhaduri":[976],"colleagues,1":[978],"analyzed":[981],"freshly":[982],"excised":[983],"GBMs":[984],"scRNA-seq":[986],"and,":[987],"studies,":[991],"each":[994,1286],"includes":[996],"differentiated":[999],"addition":[1002],"populations,":[1007],"exact":[1009],"mixture":[1010],"creates":[1012],"composition.":[1016],"To":[1017,1453],"better":[1020],"provenance":[1024],"non-immune":[1027],"created":[1032],"atlas":[1034,1471],"types":[1038,1066,1141,1314,1446,1594],"states":[1040],"mapping":[1042],"onto":[1045],"reference":[1047],"framework":[1048],"developing":[1054,1156,2079],"adult":[1056,1165],"brain.":[1058],"variety":[1063],"expressing":[1067,1142],"marker":[1068,1178,1200],"glioma":[1071],"stem":[1072,1100,1108,1119,1151,1691,1961],"(GSCs)":[1074],"could":[1075],"exist":[1076],"single":[1079,1107,1124],"some":[1082],"having":[1084],"clusters":[1086],"GSCs.":[1088,1262],"These":[1089,1587],"results":[1090,1244],"somewhat":[1092],"iconoclastic":[1093],"prevailing":[1096],"biology":[1102,2090],"purports":[1104],"initiate":[1111],"sustain":[1113],"emerges":[1121],"origin.":[1127,1555,1922],"analysis,":[1130],"observed":[1133,1974],"representation":[1134],"OPCs,":[1136],"astrocytes,":[1137],"neuronal":[1139],"GSC":[1143,1177,1289,1312],"markers.":[1144],"Furthermore,":[1145],"outer":[1146],"radial":[1147,1238,1547],"glia":[1148,1239,1548],"(oRG),":[1149],"brain":[1157,1214,1345,1436,1509,1535,1561,1657],"believed":[1160],"normal":[1166],"brain,":[1167],"appeared":[1168],"distinct":[1171,1653],"type":[1173],"strongly":[1175],"GBM.":[1181,1328],"oRG-like":[1187,1204,1260,1272],"GSCs":[1188,1205],"express":[1189],"protein":[1191,1717],"tyrosine":[1192],"phosphatase":[1193],"zeta":[1195],"1":[1196],"(PTPRZ1),":[1197],"oRG.":[1202],"PTPRZ1-positive":[1203,1219],"migratory":[1208],"system,":[1217],"invasive":[1224],"Knockdown":[1227],"PTPRZ1":[1229,1247],"resulted":[1230],"downregulation":[1232],"markers":[1236],"identity.":[1240],"Taken":[1241],"together,":[1242],"these":[1243,1494,1673,1682,1979,2032,2075],"suggest":[1245],"plays":[1248],"defining":[1252],"highly":[1254],"invasive,":[1255],"tumorigenic":[1256],"signaling":[1257,1633],"axis":[1258],"While":[1263],"recognize":[1266],"unique":[1268],"GSCs,":[1273],"point":[1276],"possibility":[1279],"spatial":[1281],"temporal":[1283,1541],"roles":[1284],"perhaps":[1292],"acting":[1294],"parallel":[1296],"promote":[1298],"standard-of-care":[1306],"therapy.":[1307],"Recognizing":[1308],"characterizing":[1310],"step":[1318],"towards":[1319],"identifying":[1320],"targets":[1321],"pursue":[1323],"drug":[1324],"discovery":[1325],"efforts":[1326],"against":[1327],"Embryonal":[1329],"multilayered":[1332],"rosettes":[1333],"(ETMRs)":[1334],"histologically":[1337],"diverse":[1338],"molecularly":[1340],"defined":[1341],"aggressive":[1344],"primarily":[1347,1449],"occurring":[1348],"infants":[1350],"young":[1353],"children":[1354],"extremely":[1357],"poor":[1358],"prognosis.":[1359],"Up":[1360],"90%":[1362],"ETMRs":[1364,1513,1600,1621,1651,1845,1904],"characterized":[1366,1665],"19q13.41":[1372],"microRNA":[1373,1915],"cluster":[1374,1895],"(C19MC)":[1375],"fusion":[1377,1758],"promoter":[1380,1773],"brain-specific":[1383],"TTYH1.1":[1386],"Despite":[1387],"knowledge":[1388],"most":[1391],"frequent":[1392],"lesion":[1394],"disease,":[1397],"our":[1398,2092],"cellular,":[1402],"genomic,":[1403],"transcriptional":[1405,1648],"basis":[1406],"limited.":[1409],"Three":[1410],"advances":[1413,2087],"illuminate":[1414],"underpinnings":[1419],"ETMR,":[1421],"expand":[1422],"future":[1423],"opportunities,":[1425],"offer":[1427],"potential":[1428,2102],"strategies.":[1430],"Possible":[1431],"Origins":[1432],"-":[1433],"Several":[1434],"pediatric":[1435,1560],"including":[1438,1507,1861],"ETMRs,":[1439,1879,1978],"arise":[1443],"normally":[1447],"embryonic":[1451,1776],"development.":[1452],"explore":[1454],"concept,":[1456],"paper":[1460],"Nature":[1462,1820],"Genetics":[1463],"Jessa":[1464],"generated":[1467],"transcriptome":[1470],"murine":[1475],"embryonal":[1476,1656,1669],"pons":[1477],"forebrain":[1479],"profiling":[1481,1649],">65,000":[1482],"allowed":[1485],"identification":[1486],"191":[1488],"populations.2":[1490],"Gene":[1491],"developmental":[1495,1527,1604,1671,1678,2051,2063],"projected":[1500],"across":[1501,1796],"240":[1502],"bulk":[1504],"RNA-sequencing":[1505],"samples,":[1506,1947],"186":[1508],"samples.":[1512],"segregated":[1518],"pathologies":[1522],"based":[1523],"distinctive":[1526],"population,":[1529],"early":[1533,1575,1677,1775],"fetal":[1534],"(13\u201318":[1536],"post-conception":[1537],"weeks).":[1538],"Assessment":[1539],"TTYH1":[1542],"suggested":[1544],"prenatal":[1545],"neurogenic":[1546],"possible":[1551,1590],"ETMR":[1552,1568,1636,1743,1829,1898,1930,1969,2009,2089],"line":[1557],"entities,":[1563],"propose":[1566],"remain":[1571],"developmentally":[1572],"trapped":[1573],"neural":[1576,1670,1690],"progenitors":[1577],"unable":[1580],"complete":[1582],"differentiation,":[1584],"propagating":[1585],"oncogenesis.":[1586],"findings":[1588,1674],"provide":[1589,2036],"insight":[1591],"modeling":[1598],"underscore":[1602],"necessary":[1606],"neoplastic":[1608],"transformation":[1609],"ETMR.":[1611,2084],"Collusion":[1612],"Partners":[1614],"Crime\u2014Another":[1616],"detailed":[1617],"investigation":[1619],"Cancer":[1624],"Cell":[1625],"investigated":[1626],"C19MC":[1631,1684,1708,1847,1874,1890,2046],"downstream":[1632],"contributes":[1634],"growth.3":[1639],"confirmed":[1643],"both":[1645,1722],"methylation":[1646,1900],"infancy":[1660],"enrichment":[1667,1957,2049],"pathways;":[1672],"highlight":[1675],"origins":[1680],"miRNAs":[1685,1709],"upregulated":[1686],"involved":[1688],"suppressor":[1700,1716],"proteins":[1701],"p21,":[1702],"p27,":[1703],"RBL2.":[1705],"Most":[1706],"importantly,":[1707],"inhibit":[1713],"TTP":[1718],"consequently":[1720,2027],"upregulate":[1721],"LIN28A":[1723],"MYCN.":[1725],"This":[1726],"establishes":[1727],"C19MC-LIN28A-MYCN":[1729,1746],"oncogenic":[1730,2059,2099],"circuit":[1731],"hypothesized":[1734],"formation.":[1744],"loop":[1747],"amplified":[1749],"hybrid":[1752],"super-enhancer":[1753],"formed":[1754,1996],"TTYH1-C19MC":[1757],"bringing":[1759],"together":[1760,1893],"enhancers":[1763],"long-range":[1768],"MYCN":[1772],"enhancers.":[1777],"Other":[1778],"Candidates":[1779],"Suggest":[1780],"Unifying":[1781],"Pathways\u2014What":[1782],"defines":[1783],"10%":[1785,1843],"non-C19MC-amplified":[1787],"ETMRs?":[1788],"Can":[1789],"we":[1790],"learn":[1791],"mutations":[1795,1854],"course":[1801],"understand":[1805],"common/distinct":[1806],"pathways":[1807],"ETMRS?":[1809],"study":[1812],"authored":[1813],"Lambo":[1815],"al,":[1817],"2019,":[1822],"characteristics":[1825],"193":[1827],"samples":[1830,1837,1954],"23":[1834],"matched":[1835],"relapsed":[1836],"described.4":[1839],"approximately":[1842],"amplification,":[1848,1891],"identified":[1851],"either":[1852],"germline":[1853],"DICER1":[1856],"microRNA-related":[1859],"aberrations,":[1860,1908],"miR-17-92miRNA":[1865],"cluster,":[1866],"C19MC-MYO9B":[1867],"fusions,":[1868],"breakpoints":[1871],"affecting":[1872],"locus.":[1875],"Importantly,":[1876],"however,":[1877],"all":[1878,1903],"regardless":[1880],"location,":[1882],"histology,":[1883],"absence":[1888],"analysis":[1896],"profiles.":[1901],"Additionally,":[1902],"harbored":[1905],"copy-number":[1907],"structural":[1910,1933],"instability,":[1911],"patterns":[1913],"suggesting":[1917],"When":[1923],"genomics":[1925],"compared,":[1932],"variants":[1934,1941],"maintained;":[1936],"contrast,":[1938],"somatic":[1939],"single-nucleotide":[1940],"likely":[1948,2072],"secondary":[1949],"platinum-based":[1951],"treatment.":[1952],"Recurrent":[1953],"additionally":[1955],"cell-like":[1962],"differentiation":[1966],"Consistent":[1971],"instability":[1976,2043],"have":[1985],"R-loops":[1989],"region":[1992,2047],"surrounding":[1993],"C19MC,":[1994],"stalled":[1998],"polymerase":[2000],"leading":[2001],"breakpoints.":[2005],"Combination":[2006],"topotecan,":[2012],"topoisomerase":[2014],"I":[2015],"inhibitor,":[2016],"PARP":[2019],"inhibitor":[2020],"pamiparib":[2021],"synergistically":[2022],"R-loop":[2024],"damage.":[2030],"Overall,":[2031],"manuscripts":[2034],"collectively":[2035],"clues":[2038],"related":[2039],"regulatory":[2052],"elements":[2053],"resulting":[2054],"synthesis":[2056],"program":[2060],"tied":[2061],"(Fig.":[2067],"1).":[2068],"Future":[2069],"investigations":[2070],"will":[2071],"capitalize":[2073],"discoveries":[2077],"pre-clinical":[2080],"strategies":[2082],"Recent":[2085],"scientific":[2086],"refine":[2091],"tumor\u2019s":[2096],"origins,":[2098],"mechanisms,":[2100],"vulnerabilities.":[2104]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}